EP0419576A4 - Enterically transmitted non-a/non-b hepatitis viral agent - Google Patents

Enterically transmitted non-a/non-b hepatitis viral agent

Info

Publication number
EP0419576A4
EP0419576A4 EP19890907985 EP89907985A EP0419576A4 EP 0419576 A4 EP0419576 A4 EP 0419576A4 EP 19890907985 EP19890907985 EP 19890907985 EP 89907985 A EP89907985 A EP 89907985A EP 0419576 A4 EP0419576 A4 EP 0419576A4
Authority
EP
European Patent Office
Prior art keywords
viral agent
hepatitis viral
enterically transmitted
enterically
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP19890907985
Other versions
EP0419576A1 (en
Inventor
Gregory R. Reyes
Daniel W. Bradley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THE GOVERNMENT OF THE UNITED STATES OF AMERICA C/
Genelabs Technologies Inc
Original Assignee
US Department of Health and Human Services
Genelabs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26903718&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0419576(A4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by US Department of Health and Human Services, Genelabs Inc filed Critical US Department of Health and Human Services
Publication of EP0419576A1 publication Critical patent/EP0419576A1/en
Publication of EP0419576A4 publication Critical patent/EP0419576A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
EP19890907985 1988-06-17 1989-06-16 Enterically transmitted non-a/non-b hepatitis viral agent Ceased EP0419576A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20899788A 1988-06-17 1988-06-17
US208997 1988-06-17
US33667289A 1989-04-11 1989-04-11
US336672 1989-04-11

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP96200030 Division 1996-01-05

Publications (2)

Publication Number Publication Date
EP0419576A1 EP0419576A1 (en) 1991-04-03
EP0419576A4 true EP0419576A4 (en) 1991-11-27

Family

ID=26903718

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890907985 Ceased EP0419576A4 (en) 1988-06-17 1989-06-16 Enterically transmitted non-a/non-b hepatitis viral agent

Country Status (7)

Country Link
EP (1) EP0419576A4 (en)
JP (5) JPH03506026A (en)
KR (1) KR0180530B1 (en)
AU (2) AU3748489A (en)
CA (1) CA1341464C (en)
SG (1) SG49225A1 (en)
WO (2) WO1989012641A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5789559A (en) * 1988-06-17 1998-08-04 Genelabs Technologies, Inc. DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent
US5741490A (en) * 1988-06-17 1998-04-21 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
WO1989012641A1 (en) * 1988-06-17 1989-12-28 Genelabs Incorporated Enterically transmitted non-a/non-b hepatitis viral agent
US6455492B1 (en) * 1988-06-17 2002-09-24 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
US5824649A (en) * 1988-06-17 1998-10-20 Genelabs Technologies, Inc. DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof
US5686239A (en) * 1988-06-17 1997-11-11 Genelabs Technologies, Inc. Hepatitis E virus peptides and methods
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
IE65172B1 (en) 1989-12-18 1995-10-04 Wellcome Found Viral agent
EP0447984A1 (en) * 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmune globulin against hepatitis C virus and method for making same
KR0178399B1 (en) * 1990-04-05 1999-04-01 프랭크 쿵 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
AU8544591A (en) * 1990-09-07 1992-03-30 Board Of Regents Of The University Of Oklahoma, The Antigens associated with polymyositis and with dermatomyositis
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
MY111880A (en) * 1992-03-27 2001-02-28 Smithkline Beecham Biologicals S A Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2606515A1 (en) * 1986-11-07 1988-05-13 Pasteur Institut Method for isolating a novel viral agent and the antigen associated therewith, viral agent and antigen obtained by this method and method for detecting the said antigen using a suitable immunological reagent
FR2609807A2 (en) * 1987-02-11 1988-07-22 Pasteur Institut Immunological reagents for the detection of viral hepatitis NANB, processes for preparing them and their applications in processes for the detection of viral hepatitis NANB and as therapeutic agents
WO1989012641A1 (en) * 1988-06-17 1989-12-28 Genelabs Incorporated Enterically transmitted non-a/non-b hepatitis viral agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
WO1985001517A1 (en) * 1983-09-30 1985-04-11 Massachusetts Institute Of Technology PRODUCTION OF cDNA REPRESENTING HEPATITIS A VIRAL SEQUENCES

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2606515A1 (en) * 1986-11-07 1988-05-13 Pasteur Institut Method for isolating a novel viral agent and the antigen associated therewith, viral agent and antigen obtained by this method and method for detecting the said antigen using a suitable immunological reagent
FR2609807A2 (en) * 1987-02-11 1988-07-22 Pasteur Institut Immunological reagents for the detection of viral hepatitis NANB, processes for preparing them and their applications in processes for the detection of viral hepatitis NANB and as therapeutic agents
WO1989012641A1 (en) * 1988-06-17 1989-12-28 Genelabs Incorporated Enterically transmitted non-a/non-b hepatitis viral agent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANN. INST. PASTEUR/VIROL, vol. 137 E, 1986, pages 225-232, Elsevier, Paris, FR; J.L. SARTHOU et al.: "Characterization of an antigen-antibody system associated with epidimic non-A,non-B hepatitis in West Africa and experimental transmission of an infectious agent to primates" *
See also references of WO8912462A1 *

Also Published As

Publication number Publication date
JP2005053924A (en) 2005-03-03
KR0180530B1 (en) 1999-03-20
JP2002097198A (en) 2002-04-02
KR900701317A (en) 1990-12-01
SG49225A1 (en) 1998-05-18
WO1989012641A1 (en) 1989-12-28
CA1341464C (en) 2004-11-09
JPH03506026A (en) 1991-12-26
AU639209B2 (en) 1993-07-22
JP2000184895A (en) 2000-07-04
JP2007031440A (en) 2007-02-08
EP0419576A1 (en) 1991-04-03
AU3748489A (en) 1990-01-12
JP4072604B2 (en) 2008-04-09
WO1989012462A1 (en) 1989-12-28
AU3857489A (en) 1990-01-12

Similar Documents

Publication Publication Date Title
GB2239245B (en) Post-transfusional non-A non-B hepatitis viral polypeptides
EP0423239A4 (en) Post-transfusion, non-a, non-b hepatitis virus and antigens
EP0058676A4 (en) Non-a, non-b hepatitis assay and vaccine.
PL324906A1 (en) Vaccines against viral hepatitis of c type
HU912118D0 (en) Non-a, non-b hepatitis virus particles
EP0419576A4 (en) Enterically transmitted non-a/non-b hepatitis viral agent
GB2108527B (en) Non-a non-b hepatitis virus
PL321966A1 (en) Vaccine against viral hepatitis of b type
CA2005950A1 (en) Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein
NZ222465A (en) Nanb (non a, non b hepatitis viral) antigen
AU6860891A (en) Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide
HUT58371A (en) Recombinant virus of marek-disease
EP0451891A3 (en) Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus
EP0531365A4 (en) Diagnosis and treatment of viral hepatitis
EP0460056A4 (en) Non-a, non-b hepatitis hepatocyte cell culture
IL73973A0 (en) Detection of non-a,non-b hepatitis
EP0093438A3 (en) Non-a, non-b hepatitis antigen
EP0532746A4 (en) Assay for non-a non-b hepatitis
DE3175439D1 (en) Non-a, non-b hepatitis assay and vaccine
EP0536838A3 (en) Non-a, non-b peptides
AU540153B2 (en) Detection of non-a, non-b hepatitis associated antigen
IE891804L (en) Nonhyperglycosylated hepatitis b virus proteins
IE880242L (en) Hepatitis b virus antigens.
ZA912581B (en) Hepatitis c virus epitopes
NO912459L (en) NON-A NON-B HEPATITE VIRUS PARTICLES.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19901217

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: REYES, GREGORY, R.

Inventor name: BRADLEY, DANIEL, W.

A4 Supplementary search report drawn up and despatched

Effective date: 19911007

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19920403

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GENELABS TECHNOLOGIES, INC.

Owner name: THE GOVERNMENT OF THE UNITED STATES OF AMERICA C/

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

APAB Appeal dossier modified

Free format text: ORIGINAL CODE: EPIDOS NOAPE

APAB Appeal dossier modified

Free format text: ORIGINAL CODE: EPIDOS NOAPE

APAD Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOS REFNE

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20040926

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1013793

Country of ref document: HK